treatment limitations in dlbcl
Published 4 years ago • 299 plays • Length 3:15Download video MP4
Download video MP3
Similar videos
-
4:05
selecting therapy for relapsed-refractory dlbcl
-
2:41
treatment options for relapsed-refractory dlbcl
-
6:43
current treatment approach to relapsed/refractory dlbcl
-
1:20
limitations of car t-cell therapy for dlbcl
-
2:54
selecting therapy for relapsed-refractory dlbcl
-
4:44
standard approach to treating dlbcl
-
4:46
treatment of r/r dlbcl: cd19-targeted monoclonal antibodies
-
1:24
unmet needs remain in the diffuse large b-cell lymphoma treatment paradigm
-
0:42
targeted therapies for dlbcl treatment
-
1:12
current treatment options for dlbcl besides r-chop chemotherapy
-
5:55
car t-cell therapy in dlbcl
-
1:39
managing early & late relapse after first-line therapy for dlbcl
-
2:15
vipor: a multi-targeted therapy for the treatment of r/r dlbcl
-
1:55
initial steps for treatment of dlbcl
-
3:39
future use of novel therapy in dlbcl
-
1:04
the potential of targeted therapy in dlbcl: open questions
-
20:48
current upfront management of dlbcl
-
0:34
rationale for genetic testing in patients with dlbcl
-
1:45
improving the frontline treatment of dlbcl